Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 281

2.

Severe refractory autoimmune hemolytic anemia with both warm and cold autoantibodies that responded completely to a single cycle of rituximab: a case report.

Gupta S, Szerszen A, Nakhl F, Varma S, Gottesman A, Forte F, Dhar M.

J Med Case Rep. 2011 Apr 19;5:156. doi: 10.1186/1752-1947-5-156.

3.

[The long-term efficacy and safety of rituximab combined with cyclophosphamide in treatment of seven patients with refractory and recurrent autoimmune hemolytic anemia].

Liu H, Xing LM, Wang HQ, Wu YH, Qu W, Liang Y, Wang GJ, Song J, Wang XM, Guan J, Li LJ, Fu R, Shao ZH.

Zhonghua Nei Ke Za Zhi. 2012 Jun;51(6):456-9. Chinese.

PMID:
22943757
4.

Adult Evans syndrome: complete hematologic recovery with steroids and rituximab: a case report.

Santiago-Ríos KJ, Reyes O, Cruz A, Rodríguez-Pabón N, Cáceres W.

Bol Asoc Med P R. 2010 Apr-Jun;102(2):33-6.

PMID:
20939201
5.

Prompt and sustained response of a steroid-refractory autoimmune hemolytic anemia to a rituximab-based therapy in a chronic lymphocytic leukemia patient.

Gentile M, Lucia E, Iorio C, Vigna E, Mazzone C, Morelli R, Bisconte MG, Gentile C, Morabito F.

Cancer Chemother Pharmacol. 2008 Sep;62(4):741-3. Epub 2007 Dec 7.

PMID:
18064461
6.

Rituximab is an effective and safe therapeutic alternative in adults with refractory and severe autoimmune hemolytic anemia.

Peñalver FJ, Alvarez-Larrán A, Díez-Martin JL, Gallur L, Jarque I, Caballero D, Díaz-Mediavilla J, Bustelos R, Fernández-Aceñero MJ, Cabrera JR; Multi-institutional Retrospective Study on the use of rituximab in refractory AIHA.

Ann Hematol. 2010 Nov;89(11):1073-80. doi: 10.1007/s00277-010-0997-y. Epub 2010 Jun 5.

PMID:
20526716
7.

[Successful treatment with rituximab in a patient with refractory mixed-type autoimmune hemolytic anemia].

Ono K, Sato T, Iyama S, Tatekoshi A, Hashimoto A, Kamihara Y, Horiguchi H, Kikuchi S, Takada K, Hayashi T, Miyanishi K, Sato Y, Takimoto R, Kobune M, Kato J.

Rinsho Ketsueki. 2013 Nov;54(11):2053-5. Japanese.

PMID:
24305538
8.

Rituximab for treatment of autoimmune hemolytic anemia.

Kuzmanovic M, Jurisic V.

Indian Pediatr. 2012 Aug;49(8):672-4.

9.

Sustained response to low-dose rituximab in idiopathic autoimmune hemolytic anemia.

Barcellini W, Zaja F, Zaninoni A, Imperiali FG, Di Bona E, Fattizzo B, Consonni D, Cortelezzi A, Zanella A.

Eur J Haematol. 2013 Dec;91(6):546-51. doi: 10.1111/ejh.12199. Epub 2013 Oct 3.

PMID:
24033754
10.

B-cell depletion with rituximab as treatment for immune hemolytic anemia and chronic thrombocytopenia.

Zaja F, Iacona I, Masolini P, Russo D, Sperotto A, Prosdocimo S, Patriarca F, de Vita S, Regazzi M, Baccarani M, Fanin R.

Haematologica. 2002 Feb;87(2):189-95. Erratum in: Haematologica 2002 Mar;87(3):336.

11.

[Successful treatment with rituximab for autoimmune hemolytic anemia associated with chronic lymphocytic leukemia].

Tanaka Y, Ito Y, Yoshizawa S, Fujimoto H, Gotoh M, Tauchi T, Kimura Y, Ohyashiki K.

Rinsho Ketsueki. 2013 Feb;54(2):229-31. Japanese.

PMID:
23470833
12.

The role of rituximab in adults with warm antibody autoimmune hemolytic anemia.

Dierickx D, Kentos A, Delannoy A.

Blood. 2015 May 21;125(21):3223-9. doi: 10.1182/blood-2015-01-588392. Epub 2015 Mar 31. Review.

13.

Brucellosis-induced autoimmune hemolytic anemia treated with rituximab.

Bourantas LK, Pappas G, Kapsali E, Gougopoulou D, Papamichail D, Bourantas KL.

Ann Pharmacother. 2010 Oct;44(10):1677-80. doi: 10.1345/aph.1P249. Epub 2010 Sep 7.

PMID:
20823278
14.

Rituximab in steroid refractory autoimmune hemolytic anemia.

Gupta N, Sharma S, Seth T, Mishra P, Mahapatra M, Kumar S, Kapoor R, Agarwal N.

Indian J Pediatr. 2012 Jun;79(6):803-5. doi: 10.1007/s12098-011-0544-4. Epub 2011 Aug 10.

PMID:
21830023
15.
16.

Successful rituximab treatment of refractory hemophagocytic lymphohistiocytosis and autoimmune hemolytic anemia associated with systemic lupus erythematosus.

So MW, Koo BS, Kim YJ, Kim YG, Lee CK, Yoo B.

Mod Rheumatol. 2014 Sep;24(5):855-7. doi: 10.3109/14397595.2013.874740. Epub 2014 Feb 11.

PMID:
24517558
17.

Long lasting remission by rituximab in a patient with primary cold agglutinin autoimmune haemolytic anaemia.

Glaser M, Glaser A, Skalicky M.

Wien Klin Wochenschr. 2011 Nov;123(21-22):680-3. doi: 10.1007/s00508-011-0060-6. Epub 2011 Sep 28.

PMID:
21947363
19.

Successful treatment with rituximab of an infant with refractory autoimmune hemolytic anemia.

Moriya K, Matsuhashi T, Onuma M, Niizuma H, Rikiishi T, Asada H, Suzuki J, Sasahara Y, Kure S.

Int J Hematol. 2013 Aug;98(2):237-9. doi: 10.1007/s12185-013-1374-0. Epub 2013 May 24.

PMID:
23702915
20.

A multi-centre retrospective study of rituximab use in the treatment of relapsed or resistant warm autoimmune haemolytic anaemia.

Maung SW, Leahy M, O'Leary HM, Khan I, Cahill MR, Gilligan O, Murphy P, McPherson S, Jackson F, Ryan M, Hennessy B, McHugh J, Goodyer M, Bacon L, O'Gorman P, Nee A, O'Dwyer M, Enright H, Saunders J, O'Keeffe D.

Br J Haematol. 2013 Oct;163(1):118-22. doi: 10.1111/bjh.12486. Epub 2013 Aug 2.

PMID:
23909468

Supplemental Content

Support Center